Zhiming Mao

6PUBLICATIONS
35CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 23, 2026
PD-1 regulates latent effector differentiation of thymic cytotoxic CD8+ T cells.

|Aug 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity.

Haidong Dong, Hyoungjun Ham, Whitney Barham

|Feb 14, 2025
Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control.

Hyoungjun Ham, Jacob B Hirdler, Daniel T Bihnam

|Jan 27, 2025
PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunity.

Zhiming Mao, Jacob B Hirdler, Joanina K Gicobi

|Nov 15, 2023
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation.

Joanina K Gicobi, Zhiming Mao, Grace DeFranco

|Jul 28, 2023
Clinical and cellular phenotypes resulting from a founder mutation in IL10RB.

Zhiming Mao, Michael J Betti, Miguel A Cedeno

Pageof 1

Frequent Collaborators

4 joint publications

Haidong Dong

3 joint publications

Daniel D Billadeau

3 joint publications

Fabrice Lucien-Matteoni

2 joint publications

Henrique Borges da Silva